Taiyen Biotech Co Ltd Total Liabilities
Taiyen Biotech Co Ltd total liabilities. Based on the latest financial reports, Taiyen Biotech Co Ltd (1737) has total liabilities worth NT$1.67 Billion TWD (≈ $52.60 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Taiyen Biotech Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Taiyen Biotech Co Ltd (2003–2025)
Total liabilities of Taiyen Biotech Co Ltd from 2003 to 2025. This chart illustrates how Taiyen Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Taiyen Biotech Co Ltd to see how much of total assets are deployed in long-term investments.
Taiyen Biotech Co Ltd Competitors by Total Liabilities
The table below lists competitors of Taiyen Biotech Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Phu Nhuan Jewelry JSC
VN:PNJ
|
Vietnam | ₫6.89 Trillion |
|
Oceanhawk Acquisition Corp. Class A Ordinary Shares
NASDAQ:OHAC
|
USA | $7.01 Million |
|
Ard Grup Bilisim Teknolojileri AS
IS:ARDYZ
|
Turkey | TL2.11 Billion |
|
TBI Motion Technology Co Ltd
TW:4540
|
Taiwan | NT$4.15 Billion |
|
Anhui Provincial Architectural Design and Research Institute Co.Ltd.
SHE:301167
|
China | CN¥369.32 Million |
|
JVM Co. Ltd
KQ:054950
|
Korea | ₩90.81 Billion |
|
Shih Wei Navigation Co Ltd
TW:5608
|
Taiwan | NT$7.97 Billion |
|
Fiducian Group Ltd
AU:FID
|
Australia | AU$20.44 Million |
Liability Composition Analysis (2003–2025)
This chart breaks down Taiyen Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Taiyen Biotech Co Ltd's balance sheet.
Liquidity & Leverage Metrics
Taiyen Biotech Co Ltd Total Liabilities Ratios Explained
Taiyen Biotech Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Taiyen Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Taiyen Biotech Co Ltd (2003–2025)
The table below shows the annual total liabilities of Taiyen Biotech Co Ltd from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$1.45 Billion ≈ $45.64 Million |
-15.45% |
| 2024-12-31 | NT$1.71 Billion ≈ $53.99 Million |
-3.24% |
| 2023-12-31 | NT$1.77 Billion ≈ $55.79 Million |
+14.27% |
| 2022-12-31 | NT$1.55 Billion ≈ $48.83 Million |
-20.70% |
| 2021-12-31 | NT$1.95 Billion ≈ $61.57 Million |
+36.33% |
| 2020-12-31 | NT$1.43 Billion ≈ $45.16 Million |
-1.05% |
| 2019-12-31 | NT$1.45 Billion ≈ $45.64 Million |
+23.77% |
| 2018-12-31 | NT$1.17 Billion ≈ $36.87 Million |
-4.74% |
| 2017-12-31 | NT$1.23 Billion ≈ $38.71 Million |
+15.14% |
| 2016-12-31 | NT$1.07 Billion ≈ $33.62 Million |
+7.77% |
| 2015-12-31 | NT$990.08 Million ≈ $31.19 Million |
+8.42% |
| 2014-12-31 | NT$913.15 Million ≈ $28.77 Million |
+109.12% |
| 2013-12-31 | NT$436.66 Million ≈ $13.76 Million |
+27.49% |
| 2012-12-31 | NT$342.49 Million ≈ $10.79 Million |
-3.94% |
| 2011-12-31 | NT$356.53 Million ≈ $11.23 Million |
-3.47% |
| 2010-12-31 | NT$369.36 Million ≈ $11.64 Million |
+12.23% |
| 2009-12-31 | NT$329.10 Million ≈ $10.37 Million |
+7.40% |
| 2008-12-31 | NT$306.42 Million ≈ $9.65 Million |
-16.72% |
| 2007-12-31 | NT$367.92 Million ≈ $11.59 Million |
-25.99% |
| 2006-12-31 | NT$497.10 Million ≈ $15.66 Million |
-46.31% |
| 2005-12-31 | NT$925.79 Million ≈ $29.17 Million |
-53.50% |
| 2004-12-31 | NT$1.99 Billion ≈ $62.73 Million |
-52.17% |
| 2003-12-31 | NT$4.16 Billion ≈ $131.13 Million |
-- |
About Taiyen Biotech Co Ltd
Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. It offers seawater chemicals; toothpaste, mouthwashes, and eyeglass solutions; beverages; bottled water; medical supplies; food and food additives; beauty, skincare, and cleaning products; and salt products; as well as health food and health products. The company was founded in 1952 and is … Read more